Return to content in this issue

Allergen Immunotherapy in the era of SARS-CoV-2

Compalati E¹, Erlewyn-Lajeunesse M², Ali FR³, Ojeda Fernández P⁴, Garcia Nuñez I⁵, Frati F¹, Mistrello G<sup>1

1</sup>Lofarma Scientific Department, Lofarma S.p.A., Milan
²Paediatric Allergy & Immunology, Southampton Children’s Hospital, UK
³Barts Health NHS Trust, London, UK
⁴Clínica de Asma y Alergia Dres. Ojeda, Madrid, Spain
⁵Hospital Quirónsalud, Córdoba y Campo de Gibraltar, Spain

J Investig Allergol Clin Immunol 2020; Vol. 30(6)
doi: 10.18176/jiaci.0568